Home › Funds › Venrock Adviser, LLC › DNTH
Venrock Adviser, LLC position in DNTH
DIANTHUS THERAPEUTICS INC · Health Care
Venrock Adviser, LLC reported holding 1,180,000 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$115.0M, representing 3.49% of its reported portfolio and ranking #5 among its reported holdings. Venrock Adviser, LLC has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's DNTH position evolved
Venrock Adviser, LLC first disclosed a stake in DNTH in Q3 2023 at 927,706 shares (US$12.7M). The position peaked in Q2 2026 at 1,180,000 shares, worth US$115.0M. Across 12 filings, Venrock Adviser, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,180,000 shares valued at US$115.0M. Notable position changes include a 126% increase in Q1 2024 (shares fell 14% over the following quarter), a 43% trim in Q2 2025 (shares rose 111% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 927.71K | $12.68M | New |
| Q4 2023 | 927.71K | $9.65M | Hold |
| Q1 2024 | 2.09M | $62.83M | Add |
| Q2 2024 | 2.09M | $54.20M | Hold |
| Q3 2024 | 1.74M | $47.76M | Reduce |
| Q4 2024 | 1.74M | $38.03M | Hold |
| Q1 2025 | 1.74M | $31.64M | Hold |
| Q2 2025 | 1.00M | $18.63M | Reduce |
| Q3 2025 | 960.80K | $37.81M | Reduce |
| Q4 2025 | 1.00M | $41.21M | Add |
| Q1 2026 | 1.18M | $99.03M | Add |
| Q2 2026 | 1.18M | $115.03M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNTH and 13F data
DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNTH
- Fairmount Funds Management LLC 2.54M sh · $247.33M · Q2 2026
- Avidity Partners Management LP 2.10M sh · $205.12M · Q2 2026
- Octagon Capital Advisors LP 1.84M sh · $179.53M · Q2 2026
- TCG Crossover Management, LLC 1.68M sh · $163.44M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 1.30M sh · $126.97M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.13M sh · $109.70M · Q2 2026
- BAKER BROS. ADVISORS LP 852.16K sh · $83.07M · Q2 2026
- Logos Global Management LP 800.00K sh · $77.98M · Q2 2026
- Cormorant Asset Management, LP 750.00K sh · $73.11M · Q2 2026
- BRAIDWELL LP 594.56K sh · $57.96M · Q2 2026
- MPM BioImpact LLC 420.00K sh · $40.94M · Q2 2026
- Affinity Asset Advisors, LLC 400.00K sh · $38.99M · Q2 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held DNTH?
Venrock Adviser, LLC has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Venrock Adviser, LLC's current position in DNTH?
As of Q2 2026, Venrock Adviser, LLC holds 1.18M shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $115.03M, representing 3.49% of its reported portfolio and ranking #5.
Has Venrock Adviser, LLC been buying or selling DNTH?
In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in DNTH. The position peaked in Q2 2026 at 1.18M shares.
Which other funds hold DNTH?
Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.